Undoubtedly, procedures for getting
treatment in foreign countries will vary.
Some travelers who received surgical
treatments in foreign countries suffered from post-surgery infections after they returned to their home countries, and they had to seek further medical care to treat their infections.
You need to cut the trip short, receive medical
treatment in a foreign country, and eventually be flown home on a special medical evacuation flight.
Secondly, the cost of
treatment in a foreign country is exorbitant.
If a traveler is forced to seek medical
treatment in a foreign country, most health insurers and Medicare will not cover foreign medical treatment under standard coverage.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European
countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the
foreign exchange rate of the U.S. dollar that may cause an unfavorable
foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Research at the Selective Mutism Anxiety Research and
Treatment Center (SMart Center) indicates that there is a proportion of children with Selective Mutism who come from bilingual / multilingual families, have spent time
in a
foreign country, and / or have been exposed to another language during their formative language development (ages 2 - 4 years old).
Giving further details on the matter on Kumasi - based Nhyira FM, the NDC lawmaker said, it is time for the Ghanaian government to seek better
treatment for people seeking visa from
foreign embassies
in the
country.
Freedom of Information requests have shown that most NHS trusts at best only cursorily audit the
treatment of
foreign nationals not entitled to automatic free healthcare, and GP practices do not record this information at all, despite
in many other
countries access to primary care having a nominal charge for all patients, including British visitors.
Proposed reductions
in U.S.
foreign aid would have a devastating impact on HIV
treatment and prevention programs
in countries receiving such aid, an international team of investigators reports.
Thus, while an importer may bring a dog into a U.S. territory for resale, research, or veterinary
treatment without the dog meeting the requirements of this rule, dogs originating
in a
foreign country or any U.S. territory may not be shipped from a U.S. territory into the continental United States or Hawaii for any of those purposes except as provided
in this rule.
Finally, there are some premium travel cards that will offer you medical evacuation insurance, that will fly you home for
treatment if you become sick or injured
in a
foreign country.
Here I am, an obscure non-Australian citizen living
in a
foreign country (USA), sending an Email to the Deputy Vice-Chancellor (Students and Registrar) of Macquarie University questioning the University's
treatment of one of its employees (now ex-employee?).
This coverage provides medical evacuations and covers medical expenses due to complications from medical
treatment scheduled
in a
foreign country (also called medical tourism).
If you are
in a
foreign country and caught
in a terrorist attack, your emergency medical
treatment will be covered up to the limits of the travel insurance plan.
Getting medical care for illnesses and injuries can be expensive
in some
countries, and some
foreign hospitals may require advance payment before
treatment is administered.
Repatriation Repatriation means the transportation of seriously ill or injured people from
foreign travel destinations to hospitals with appropriate
treatment facilities
in their home
country.
God forbid if they get injured or fell ill
in a
foreign country; as a part of the offered cover, the insurance provider will pay for the
treatment expenses.
Being the medical
treatments more expensive
in foreign countries, it is a wise decision if you buy student travel insurance before heading towards an unfamiliar
country.